Cubist Systematic Strategies, LLC Chimerix Inc Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.91 - $1.26 $10 - $15	12 New	12 $0
Q3 2023 Nov 14, 2023	SELL	$0.94 - $1.23 $49,833 - $65,207	-53,014 Reduced 96.0%	2,210 $2,000
Q2 2023 Aug 14, 2023	BUY	$1.1 - $1.54 $11,832 - $16,565	10,757 Added 24.19%	55,224 $66,000
Q1 2023 May 15, 2023	SELL	$1.19 - $2.09 $22,912 - $40,240	-19,254 Reduced 30.22%	44,467 $56,000
Q4 2022 Feb 14, 2023	SELL	$1.67 - $2.35 $78,688 - $110,729	-47,119 Reduced 42.51%	63,721 $118,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.76 $200,620 - $305,918	110,840 New	110,840 $214,000
Q2 2022 Aug 15, 2022	SELL	$1.34 - $5.34 $56,577 - $225,465	-42,222 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.58 - $6.8 $185,132 - $274,869	40,422 Added 2245.67%	42,222 $193,000
Q4 2021 Feb 14, 2022	SELL	$5.23 - $7.18 $253,759 - $348,373	-48,520 Reduced 96.42%	1,800 $12,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $45,856 - $67,550	-7,720 Reduced 13.3%	50,320 $311,000
Q2 2021 Aug 16, 2021	BUY	$7.54 - $9.79 $257,415 - $334,230	34,140 Added 142.85%	58,040 $464,000
Q1 2021 May 17, 2021	SELL	$4.76 - $11.25 $56,786 - $134,212	-11,930 Reduced 33.3%	23,900 $230,000
Q4 2020 Feb 16, 2021	BUY	$2.43 - $5.42 $87,066 - $194,198	35,830 New	35,830 $173,000
Q3 2020 Nov 16, 2020	SELL	$2.3 - $3.72 $12,178 - $19,697	-5,295 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $7,042 - $19,220	5,295 New	5,295 $16,000
Q1 2020 May 15, 2020	SELL	$1.27 - $2.33 $8,585 - $15,750	-6,760 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.3 - $2.72 $5,330 - $11,152	-4,100 Reduced 37.75%	6,760 $14,000
Q3 2019 Nov 14, 2019	BUY	$1.93 - $4.21 $15,650 - $34,138	8,109 Added 294.77%	10,860 $26,000
Q2 2019 Aug 14, 2019	SELL	$2.05 - $4.32 $41,145 - $86,706	-20,071 Reduced 87.95%	2,751 $12,000
Q1 2019 May 15, 2019	BUY	$1.79 - $3.12 $15,216 - $26,523	8,501 Added 59.36%	22,822 $48,000
Q4 2018 Feb 14, 2019	BUY	$2.24 - $3.9 $889 - $1,548	397 Added 2.85%	14,321 $37,000
Q3 2018 Nov 14, 2018	BUY	$3.58 - $4.9 $10,371 - $14,195	2,897 Added 26.27%	13,924 $54,000
Q2 2018 Aug 14, 2018	BUY	$4.43 - $5.14 $48,849 - $56,678	11,027 New	11,027 $52,000

Others Institutions Holding CMRX

# of Institutions

Shares Held

36.8M

Call Options Held

72.2K

Put Options Held

169K

Ra Capital Management, L.P. Boston, MA

8.8M
Shares

$8.54 Million
0.12% of portfolio
Monaco Asset Management Sam

4.38M
Shares

$4.25 Million
0.63% of portfolio
Vanguard Group Inc Valley Forge, PA

4.35M
Shares

$4.22 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

2.22M
Shares

$2.16 Million
0.03% of portfolio
Acadian Asset Management LLC Boston, MA

2.17M
Shares

$2.11 Million
0.01% of portfolio

View Full List

About CHIMERIX INC

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

More about CMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account